ArticleOncoTargets and therapy2019

Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin.

Shuzhi Zang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.